Description: | ((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane is an intermediate for the synthesis of 3-Hydroxy Bortezomib (H818150), which is a metabolite of Bortezomib (B675700); the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. |
Molecular Weight: | 180.75 |
Molecular Formula: | C7H17ClOSi |
Solubility: | Dichloromethane; Ethyl Ether |
Appearance: | Clear Colorless Oil |
References: | Nawrocki, S.T., et al. Cancer Res., 65, 11510 (2005); Drahl, C. Chem. and Eng. News, 87, 41 (2009). |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products